AR077952A1 - Resistencia contra oomycota en plantas mediada por fusion de anticuerpos - Google Patents
Resistencia contra oomycota en plantas mediada por fusion de anticuerposInfo
- Publication number
- AR077952A1 AR077952A1 ARP100103089A ARP100103089A AR077952A1 AR 077952 A1 AR077952 A1 AR 077952A1 AR P100103089 A ARP100103089 A AR P100103089A AR P100103089 A ARP100103089 A AR P100103089A AR 077952 A1 AR077952 A1 AR 077952A1
- Authority
- AR
- Argentina
- Prior art keywords
- oomycota
- resistance against
- antibody fusion
- fusion proteins
- plants mediated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
- C07K14/43581—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies from Drosophila
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Insects & Arthropods (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Virology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Proteínas de fusion que comprenden proteínas o péptidos anti-oomicoticos unidos a un anticuerpo, o fragmento de éste, que reconoce específicamente un epítopo de un Oomycota. También se relaciona con polinucleotidos que codifican a las proteínas de fusion. Las formas de realizacion de la presente solicitud son especialmente utiles para proteger a las plantas contra Oomycota. La solicitud comprende, por lo tanto, plantas transgénicas que expresan las proteínas de fusion divulgadas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09168451 | 2009-08-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR077952A1 true AR077952A1 (es) | 2011-10-05 |
Family
ID=42829976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP100103089A AR077952A1 (es) | 2009-08-24 | 2010-08-24 | Resistencia contra oomycota en plantas mediada por fusion de anticuerpos |
Country Status (8)
Country | Link |
---|---|
US (1) | US20120042416A1 (es) |
EP (1) | EP2478104A1 (es) |
AR (1) | AR077952A1 (es) |
AU (1) | AU2010288743A1 (es) |
BR (1) | BRPI1012085A2 (es) |
CA (1) | CA2754024A1 (es) |
RU (1) | RU2011133912A (es) |
WO (1) | WO2011023522A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014191146A1 (en) * | 2013-04-29 | 2014-12-04 | Agrosavfe N.V. | Agrochemical compositions comprising antibodies binding to sphingolipids |
BR112017009330A2 (pt) | 2014-11-05 | 2017-12-19 | Agrosavfe N V | planta transgênica que compreende um polinucleotídeo que codifica um domínio variável de anticorpo de cadeia pesada |
CA3097193A1 (en) | 2018-05-08 | 2019-11-14 | Phanes Therapeutics, Inc. | Anti-dll3 antibodies and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2200434A1 (en) * | 1994-09-19 | 1996-03-28 | Jacob Bakker | Gene constructs encoding crop-protecting agents, as well as transformed plants containing and expressing such constructs, and methods of controlling plague organisms and pathogensin crops |
EP1123398B1 (en) | 1998-10-16 | 2005-08-10 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Molecular pathogenicide mediated plant disease resistance |
AU2003224073C1 (en) | 2002-04-22 | 2010-03-11 | AgroProtect GmbH | Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi |
-
2010
- 2010-08-05 AU AU2010288743A patent/AU2010288743A1/en not_active Abandoned
- 2010-08-05 BR BRPI1012085A patent/BRPI1012085A2/pt not_active IP Right Cessation
- 2010-08-05 WO PCT/EP2010/061427 patent/WO2011023522A1/en active Application Filing
- 2010-08-05 CA CA2754024A patent/CA2754024A1/en not_active Abandoned
- 2010-08-05 RU RU2011133912/10A patent/RU2011133912A/ru unknown
- 2010-08-05 EP EP10740638A patent/EP2478104A1/en not_active Withdrawn
- 2010-08-05 US US13/264,224 patent/US20120042416A1/en not_active Abandoned
- 2010-08-24 AR ARP100103089A patent/AR077952A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI1012085A2 (pt) | 2019-09-24 |
AU2010288743A1 (en) | 2011-09-01 |
RU2011133912A (ru) | 2013-10-10 |
CA2754024A1 (en) | 2011-03-03 |
WO2011023522A1 (en) | 2011-03-03 |
US20120042416A1 (en) | 2012-02-16 |
EP2478104A1 (en) | 2012-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2018011364A2 (es) | Anticuerpos anti-il-33, composiciones, métodos y usos de los mismos | |
CO2018005436A2 (es) | Anticuerpos y fragmentos de anticuerpo para la conjugación sitio-específica | |
EA201591465A1 (ru) | Специфичные участки для модификации антител для получения иммуноконъюгатов | |
CR20190227A (es) | Proteínas de fusión heterodiméricas biespecíficas que contienen proteínas de fusión fc il-15/il-15ra y fragmentos de anticuerpo pd-1 | |
CY1122978T1 (el) | Αντισωματα εναντι-vla-4 | |
EA201891093A1 (ru) | Антитела, специфически связывающие pd-1, и их применение | |
CO6440515A2 (es) | Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento c3b | |
CO7250445A2 (es) | Proteínas de unión a antígeno st2 | |
CR11193A (es) | Polipeptidos, dominios variables de anticuerpos y antagonistas | |
CY1116488T1 (el) | Αντισωματα anti-προπερδινης | |
CO6602149A2 (es) | Uso combinado de vip3ab y cry1fa para el manejo de insectos resistentes | |
PE20181368A1 (es) | Moleculas de union a linfopoyetina estromal timica (tslp) y metodos de uso de las moleculas | |
BR112016022841A2 (pt) | cadeia j modificada | |
CR20170079A (es) | Agentes de unión a cd123 y usos de estos | |
CL2012000254A1 (es) | Anticuerpo aislado de unión a antígeno que se une a proteína atenuante de linfocitos b y t (btla); ácido nucleico que lo codifica; composición que comprende a dicho anticuerpo; y vector de expresión. | |
CL2014001123A1 (es) | Anticuerpos anti-il 36r; composicion farmaceutica que lo contiene; polinucleotido aislado que codifica el anticuerpo; metodo para la produccion del anticuerpo; kit de diagnostico que lo contiene. | |
CR20130132A (es) | Anticuerpos contra metalproteasa-9 de matriz | |
EA201391175A1 (ru) | Гетеродимерные иммуноглобулины | |
EA201491599A1 (ru) | Антитела к матриксной металлопротеиназе 9 | |
CR11194A (es) | Polipeptidos, dominios variables de anticuerpos y antagonistas | |
CR11434A (es) | Anticuerpos anti-amiloide humanos; composiciones, metodosy usos | |
EA201491575A1 (ru) | Антитела к матриксной металлопротеиназе 9 | |
BRPI1016204A2 (pt) | proteínas de fusão de anticorpos com sítios de ligação fcrn modificados | |
EA201990672A1 (ru) | Антитела, специфически связывающиеся с pd-1, и их функциональные фрагменты | |
BR112019001605A2 (pt) | processo para a preparação de proteína ou peptídeo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |